Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc > July 18 2011
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Comment by Jthom376on Jul 16, 2021 9:09pm
383 Views
Post# 33564495

RE:RE:RE:July 18 2011

RE:RE:RE:July 18 2011Curious on opinions... noticed a lot of oncology updates now have heavy references or terminology associated with 'vaccine.'  Additionally, a gentleman spoke with IR and he too used vaccine, vaccine, vaccine when speaking on the oncology... this to me is so indicative of a changed path or view of their science.... but maybe I'm missing it. Anyways - i had concerns when I read it and then again when another gentleman noted it during his conversations with IR. It was just different... 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities